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Disassociation between glomerular hyperfiltration and extracellular
volume in diabetic rats. The relationship of the development of glomer-
ular hyperfiltration in diabetes to changes in extracellular fluid volume
has not been previously examined. To accomplish this task, male
Wistar rats were chronically cannulated in the bladder, femoral artery
and vein, Control measurements of glomerular filtration rate (GFR),
renal plasma flow (RPF), extracellular fluid volume (ECF), and urinary
sodium excretion were performed on two separate days prior to
infusion of streptozotocin (65 mg/kg body wt i.v.). After infusion of
streptozotocin, the IDDM rats were separated into two groups: un-
treated IDDM group of rats and IDDM rats treated with insulin at doses
sufficient to normalize blood glucose (Ultralente, 2 to 8 lU/day). A third
group of normal non-diabetic rats served as time controls. Measure-
ments of renal function occurred at 1, 4, 7, 11, and 15 days after infusion
of streptozotocin. Blood glucose in the non-diabetic measurement
period averaged 137 30 mg/dl and increased from 412 55 after 24
hours in the untreated diabetic rats to 533 33 mg/dl after 15 days of
IDDM. The time controls and the insulin-treated diabetic rats did not
differ in blood glucose values at the time measurements were per-
formed. Glomerular filtration rate increased from 1.0 0.1 to 1.7 0.1
ml/min/100 g body wt by day 15 in the untreated diabetic rats with
significant increases in GFR within 24 hours. GFR of both time controls
and the insulin-treated IDDM rats did not significantly vary during the
time of the study. The increase in GFR in the untreated IDDM group
was associated with a concomitant increase in RPF. However, ECF
decreased in both the insulin treated and untreated groups by one day
after streptozotocin infusion and was less than control throughout the
15 day IDDM measurement period. Therefore, the data indicate that the
development of hyperfiltration in IDDM is not caused by ECF expan-
sion and cannot be temporally linked to changes in ECF.
Glomerular hyperfiltration is a common observation in early
insulin-dependent diabetes mellitus [1-41. This observation
occurs prior to any discernible morphologic injury (other than
hypertrophy) to either the systemic microvasculature or the
kidneys [5, 6]. Glomerular hyperfiltration is thought to contrib-
ute to the development of glomerular capillary ,hypertension
and increased glomerular basement membrane thickening,
which in turn is considered to be the precursor to increased
urinary protein excretion and glomerular microangiopathies [5,
7]. Since this early elevation in glomerular filtration rate occurs
prior to structural changes within the kidney, functional alter-
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ations were proposed, and hyperfiltration is best linked to
increases in renal plasma flow. However, the cause for in-
creased renal plasma flow is less well defined. A current
hypothesis is that fluid volume expansion (either extracellular
fluid volume or plasma volume) is a likely candidate inducing
hyperfiltration in insulin dependent diabetes (IDDM). The the-
ory that extracellular volume expansion is, in part, responsible
for the glomerular filtration is based upon studies which exam-
ined extracellular fluid volume (ECF) or plasma volume (PV) in
humans [8, 9] or animal models [3, 10] with established IDDM
and exhibiting hyperfiltration. If ECF expansion is the cause of
glomerular hyperfiltration in early IDDM, then control of
extracellular fluid volume could lessen the progression of
diabetes-related renal disease and the decline in renal function.
Bank et al placed early IDDM rats on salt restricted diets and
demonstrated a reduction in glomerular filtration rate compared
to rats on normal salt intake, and raised the possibility of this
change to reduction of ECF (approximately 10% of ECF) [11].
However, other studies have indicated no change in PV or
increased ECF in IDDM [12, 131. The actual link between
expanded ECF and the development of glomerular hyperfiltra-
tion in early IDDM has yet to be established.
The purpose of the present study is to determine if ECF
expansion can be linked to increased glomerular filtration rate
during the initiation and development of IDDM. To accomplish
this task, glomerular filtration rate, renal plasma flow, and
extracellular fluid volume were measured simultaneously in
awake, chronically catheterized rats during normal conditions
prior to infusion of streptozotocin and followed for 19 days after
development of insulin dependent diabetes. If there were an
association between ECF expansion and development of gb-
merular hyperfiltration, then following the two parameters on a
time line basis should provide evidence of functional linkage.
Both untreated and insulin treated (sufficient to normalize blood
glucose concentrations) IDDM rats were utilized in the present
study to provide two models for the examination of the rela-
tionship between ECF and GFR.
Methods
All experiments were performed on Wistar rats (Harlan
Sprague-Dawley, Indianapolis, Indiana, USA) which were
housed at the San Diego Veterans Affairs Medical Center. The
weight range of the rats was 280 to 360 g at the time of the
studies.
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Chronic cannulation procedure
Rats received at least six hours of training by sitting quietly in
a restraining cage at intervals of not more than three hours at
any one time in preparation for the conscious studies. After the
training was completed the animals were anesthetized with a
short duration anesthetic [initial i.p. injection with 65 mg/kg
body wt methohexital sodium (Brevital) and i.v. doses of 5 to 10
mg/kg body wt of Brevital thereafter as requiredi. Sterile Tygon
catheters were placed in the left femoral artery and vein. The
collateral vascular supply to the leg is sufficient to permit
maintenance of adequate vascular perfusion. The vascular
catheters were threaded under the skin, exteriorized at the back
of the neck, primed with a solution of 25% mannitol and 1,000
U/mI heparin (1:1) and plugged with pins. A 14 gauge steel
cannula, enclosed in Silastic tubing, was implanted in the
bladder and plugged with a stainless steel pin also covered in
silastic so that the animal was able to void normally through the
urethra, thus reducing the likelihood of bladder infection. This
is a modification of the preparation described in detail by Gellai
and Valtin [14] and has been utilized in other studies from our
laboratory [15]. The animals were allowed to recover for five to
seven days after the cannulation procedure prior to the initial
experiments.
Specific experimental protocols
Untreated diabetics (N = 6, group 1). After recovery from the
cannulation procedure, the rats were placed in a restraining
cage and the first of two control measurement periods was
performed prior to the infusion of streptozotocin and onset of
insulin dependent diabetes. Two to three days following the first
control measurement a second control measurement period was
performed. Immediately after the second control measurement
period, streptozotocin (65 mg/kg body wt, Sigma Chemical Co.,
St. Louis, Missouri, USA) was infused (approximately 1 mm to
perform infusion) through the femoral vein catheter while the
rat was awake and the animal returned to its cage. Measure-
ments were repeated at 1, 4, 7, 11, 15, and 19 days after
induction of diabetes. Day 19 data was eliminated from the
study due to deteriorating health of some rats with developing
ketoacidosis, clogging of the vascular catheters, incomplete
urine collections and agitation of the animal in the cage resulting
in significantly compromised renal function measurements in
the restraining cage during the study, as well as incomplete data
collection at this time point. Also, if blood sugar did not
increase to levels >300 mg/dl within four days after streptozo-
tocin and it exhibited significant glycosuria, the animal was
discarded.
Treated diabetic rats (N = 6, group 2). The protocol for the
treated group of rats is essentially the same as the untreated
diabetic except that the rats were treated during their diabetic
phase of the study with a long acting insulin (Ultralente, NOVO
Pharmaceuticals) given in the late afternoon of each day to
correspond to the nighttime feeding habits of the animals. Blood
glucose concentration was monitored daily via the femoral
artery catheter and the following dose metered accordingly (2 to
8 U/day s.c.) to maintain a blood glucose concentration at near
normal values. All animals in this group exhibited an occasional
higher than normal blood glucose during the treatment phase
and was used as an indication of successful establishment of
diabetes.
Normal non-diabetic rats (N = 4, group 3). The protocol and
measurement period sequence was the same as in the group 1
and 2 rats except that after the second measurement period,
vehicle without streptozotocin was infused and no insulin was
given to these animals. This group was utilized to provide a
control for the effects of the multiple measurement procedures
over time and to determine ii the protocol exerted any impact
on renal function or ECF.
Measurement protocol in the conscious rat
The rats were placed in a restraining cage five to seven days
after recovery from surgery and two control, pre-diabetic
measurement periods were performed to assess renal function
and ECF in the conscious non-surgically stressed condition in
each of the three groups: untreated diabetic, treated diabetic,
and normal time controls. The bladder pin was removed to
allow collection of urine. The arterial line was connected to a
pressure transducer for measurement of mean arterial pressure
(MAP) and was also utilized for blood sampling. A constant
intravenous infusion of 3H inulin (100 CiIdl) and para-amino-
hippuric acid (PAH) (1 to 2 g/dl) was given at a rate of 5
d. min . 100 g body wt1 through the venous line [15].
Differences in urinary output in groups 2 and 3 and the primary
infusion were matched with an additional infusion of isotonic
saline solution to maintain constant volume. Inulin distribution
space was measured as an index of extracellular fluid volume
during a 60-minute equilibration period [15]. In some rats the
equilibration period was extended to 80 minutes to assure that
complete equilibration was achieved, This was verified by
comparing the plasma 3H inulin concentration in the first blood
sample following the equilibration period to the following
collections. Less than 5% increase in plasma 3H inulin concen-
tration in the second blood sample obtained 20 minutes follow-
ing the first post-equilibration blood sample was utilized as the
criteria for establishment of equilibrium. This measurement was
determined by monitoring both input and urinary output of 3H
inulin. At the end of the equilibration period the total amount of
inulin in the rat was determined and assumed to be homogene-
ously distributed in extracellular space. A blood sample was
obtained and the concentration of inulin in plasma water was
measured. The total amount of inulin in the rat divided by the
plasma water concentration on inulin yielded an index of
extracellular volume. This procedure has been utilized previ-
ously by this laboratory [15]. A 100 1.d blood sample was
obtained to determine plasma catecholamine levels at the end of
the equilibration period. Also, at the end of the equilibration
period, three to four 20-minute urine collections were obtained
and the volumes measured. Arterial blood collections (S—140 .d
of whole blood) were performed bracketing each urinary col-
lection period and analyzed for hematocrit, blood glucose
concentration, and inulin, PAH, and plasma protein concentra-
tions. Urine was analyzed for 3H inulin and PAH concentration.
Studies that have been performed in glycosuric humans have
demonstrated that errors in measurement of effective renal
plasma flow can occur due to binding of glucose to PAH [16]
and can be eliminated with addition of NaOH during the
collection of urine [16]. We added 10 d of 2 N NaOH in the
urine collection vials in some of the initial studies, but found
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this to have minimal impact on the measurements of PAH
clearance in the rat and discontinued the practice. Na and K
concentrations were also measured in both serum and urine. At
the end of the experiments, the erythrocytes were reconstituted
with sterile saline and reinfused into the rat. These experiments
were repeated after infusion of streptozotocin or vehicle as
indicated in the specific experimental protocols until day 19 at
which time the final collections were obtained and the animal
euthanized for examination of the catheters for signs of infec-
tion.
Measurement of plasma volume
In a separate group of rats (N = 20), chronic cannulation was
performed of the femoral artery and vein but not the bladder
catheter. The animals were allowed to recover for five to seven
days prior to any experiments or inductiQn of insulin dependent
diabetes with streptozotocin (65 mg/kg body wt i.v., Sigma
Chemical Co.).
The rats were divided at random into four groups (N =5 in each
group) and measurements of plasma volume were performed in
the following conditions: 1) Control, untreated with streptozo-
tocin; 2) 24 hours after induction of streptozotocin diabetes; 3)
seven days after the induction of streptozotocin diabetes; and 4)15
days after the induction of streptozotocin diabetes. None of the
rats in streptozotocin-induced diabetes groups received any exog-
enous insulin or were treated for hyperglycemia in any fashion in
an effort to parallel the protocol of the untreated diabetic group in
which ECF was obtained. However, these rats were only utilized
once for plasma volume measurements since gamma emitting
radioisotopes were used and the animals could not be returned to
the animal facility.
After the rat was resting quietly in the restraining cage, blood
was withdrawn from the femoral artery catheter for measure-
ment of hematocrit, plasma protein concentration and blood
glucose concentration (<100 1.d). Following the initial blood
withdrawal, 1 ml of blood was removed and centrifuged. When
the centrifugation was complete, the plasma was reinfused into
the animal and the remaining red blood cells were labeled with
Cr51 as described by Sterling [17] and Sterling and Gray [181 for
measurement of plasma volume as previously performed in this
laboratory [19J. Albumin labeled by J125 (ICN Radiochemicals,
Irvine, California, USA) was also used as a plasma marker. The
radiolabeled red blood cells and the 1125 albumin were then
combined in isotonic saline and after aliquots were obtained to
determine total radioactivity, the remaining volume was mea-
sured and infused into the rat. Within five minutes of the
infusion, a 200 pi sample of whole blood was removed and
placed in a tube for counting on a gamma counter. Blood was
also withdrawn at 15, 30, and 60 minutes after the infusion of
the radiolabel. The zero time intercept for the J125 albumin and
Cr51 labeled erythrocytes was utilized as measures of plasma
volume. If there was not good agreement with the two methods,
then the study was discarded.
Analytic methods
Total filtration rates were calculated as previously described
[15, 20]. Renal plasma flow was determined from the clearance
of PAH. A PAH extraction ratio of 0.85 was utilized; this has
been previously shown to an average extraction ratio for the rat
[14, 211. Systemic protein concentration was determined by
analysis of femoral artery plasma. Both refractometric and the
method of Lowry et al [22] was utilized. Plasma and urinary
Na and K concentrations were determined by flame photom-
etry (Instrumentation Laboratory, Lexington, Massachusetts,
USA).
Norepinephrine, epinephrine, and dopamine concentrations
in systemic plasma in all three groups were determined by a
highly sensitive radioenzymatic assay for catecholamines pre-
viously described [23] and utilized by this laboratory [15].
Statistical analysis
Significance of the data between control and experimental
conditions was determined by analysis of variance and paired
Student's t-test where appropriate in the conscious rat studies
[24]. Time series analysis was performed by a modification of
Tukey analysis [241. Comparisons between groups were ana-
lyzed by unpaired I-test to determine significant differences.
The animals were not compared to the time control group but
rather each individual rat's control values prior to administra-
tion of streptozotocin. All data values are given as the means
SE.
Results
Effect of untreated and insulin treated IDDM on growth,
blood pressure, blood glucose, and systemic catecholamines
All three groups of rats exhibited similar initial body weights
at the start of the measurement protocols (294 3 g in control,
310 5 gin the untreated diabetic group, and 304 11 gin the
insulin treated diabetic rats). As depicted in Figure 1, the
growth of the treated diabetics and time controls were not
different, with a final weight of 360 lOin time controls and 375
15 g in the insulin-treated diabetic rats. This represents a 22%
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Fig. 1. Effect of untreated (IDDM, long dashed line) and insulin
treated diabetes (TR IDDM, short dashed line) on body weight. IDDM
rats lost weight significantly during the time course of the study (P <
0.05). TR IDDM rats' body weight increased at the same rate as the
time controls (solid line). Since there were marked differences in body
weight by day 15 in untreated versus treated diabetic rats, renal
function was normalized to 100 g body weight in the following figures.
*p < 0.05 compared to respective pre-diabetic control measurements
(day 0 values).
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Table 1. Effect of diabetes on mean arterial pressure
Control Day 1 Day4 Day 7 Day 11 Day 15
mm Hg
Time controls
IDDM
Treated IDDM
101
101
107
2
2
1
98 2
100 2
106 1
104 3
100 3
106 1
105 3
95 ia
107 2
115 a93 2
110 3
106 3
97 3
113 3
a P < 0.05 compared to respective Control period
weight gain in the time controls and a 23% weight gain in the
treated diabetic rats. However, the untreated diabetic group
actually lost a significant amount of body weight (from 310 5
to 257 6 g, P < 0.05), a 17% decrease in body weight during
the time course of the study (Fig. 1).
Mean arterial pressure (MAP) was not significantly different
among the three groups and did not change markedly during the
time course of the study (Table 1). MAP in the time control
group was 101 1 mm Hg at the beginning of the study and
fluctuated between 98 2 and 115 5 mm Hg during the 15
daytime matched study period. The untreated IDDM group
exhibited a MAP of 101 2 mm Hg prior to the induction of
diabetes, and thereafter ranged from 93 2 to 100 3 mm Hg
during the course of the 15 day study (Table 1). In the treated
IDDM group, MAP was 107 1 in the pre-diabetic measure-
ment periods and ranged from 106 Ito 113 3 mm Hg during
the treated IDDM portion of the study (Table I). Overall, the
untreated IDDM group exhibited a lower MAP during the
IDDM portion of the study compared to the time controls or the
treated IDDM groups. Glomerular hyperfiltration could not be
associated with increases in blood pressure in the untreated
IDDM group.
Blood glucose concentrations varied significantly between
the untreated IDDM rats and the time controls or the treated
IDDM rats, as depicted in Figure 2. Daily measurement of
blood glucose and injection of insulin to normalize blood
glucose was performed in the treated IDDM group with the
resulting values at the time of the measurement periods shown
in Figure 2. The pre-insulin injection values of blood glucose
determined by afternoon measurements in the treated group (2
to 4p.m.) resulted in slightly different blood glucose values than
those measured at the time of the studies, 237 14 mg/dl.
Awake, unstressed, plasma epinephrine, norepinephrine, and
dopamine concentrations are depicted in Table 2. Epinephrine
levels did not change after induction of IDDM compared to the
control pre-diabetic measurement periods in both the untreated
and treated IDDM groups. There were no changes in plasma
epinephrine levels in the time control group (Table 2). Dopam-
me concentrations varied considerably in the individual rats,
but the values during the time course of the study after
induction of IDDM was not different than the respective pre-
diabetic control values (Table 2). Also, there were no changes
in plasma norepinephrine from pre-diabetic values to values
after induction of IDDM in either the untreated or treated
IDDM groups. The time controls did not exhibit significant
alterations in plasma norepinephrine concentrations during the
time course of the study (Table 2). These data indicate that
events associated with either treated or untreated diabetes did
not alter plasma catecholamines and, as indicated by the time
controls, the study protocol and the chronic cannulation pro-
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Fig. 2. Changes in blood glucose during the 15 day study period in
IDDM (long dashed line), insulin treated diabetics (TR IDDM, short
dashed line), and time controls (solid line). IDDM rats rapidly increased
their blood glucose and developed glycosuria within 24 hours. Blood
glucose in TR IDDM rats did not significantly differ from day 0(pre-streptozotocin infusion control measurements) during the time of
the study or compared to the time control group. *D < 0.05 compared
to respective control measurements (day 0 values).
cedure do not appear to produce any changes in circulating
catecholamine concentrations.
Effects of untreated and treated IDDM on renal
hemodynamics
Urine flow from day 1 to day 15 is depicted in Figure 3 and is
compared to the control period (indicated by day 0). Urine flow
increased significantly within 24 hours of IDDM and remained
greater than control throughout the study period. Urine flow
was also significantly increased in the insulin-treated IDDM rats
which maintained relatively good glycemic control at the time
of the measurement period. The untreated IDDM group dem-
onstrated marked glycosuria whereas the treated group had no
glucose in the urine during the measurement period. The time
control group did not exhibit any significant change in urine
flow during the course of the study (Fig. 3).
Sodium excretion rate increased significantly after 24 hours in
the untreated IDDM group and remained significantly increased
during the course of the study. In the insulin-treated IDDM
group, urinary sodium excretion was also significantly in-
creased after onset of diabetes compared to the pre-diabetic
phase of the study. However, the magnitude of the increase was
less than that of the untreated IDDM group (Fig. 4).
The increase in glomerular filtration rate in the untreated
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Table 2. Effect of diabetes on plasma catecholamines
Time controls IDDM Treated IDDM
Con, DiabeticCon. DiabeticCon. Con.
Epinephrine
Norepinephnne
Dopamjne
71 24 83 19
69 4 97 15
41 9 36 8
65 6
196 53
195 55
79 24
256 39
308 82
118 10
163 28
56 3
159 30
145 26
71±16
Data are presented as pg/ml. Abbreviation Con, is control group.
Fig. 3. Effects of untreated (IDDM, long dashed line) and insulin
treated (TR IDDM, short dashed line) on urine flow during the study
period. The solid line represents the time controls which did not
significantly alter urine flow during the time course of the study. Urine
flow significantly increased in both IDDM and TR IDDM rats compared
to control (day 0) and to the time controls (except for TR IDDM to time
controls at day 11). However, by day 11, IDDM rats had a significantly
greater urine flow compared to TR IDDM rats. *D < 0.05 compared to
respective day 0 control measurements.
IDDM rats was significant after 24 hours of untreated strepto-
zotocin-induced diabetes, and increased progressively during
the time course of the study (Fig. 5). Overall, absolute GFR
(non-normalized for body wt) increased from 3.2 0.1 mLfmin
in the control measurements to 4.3 0.1 mI/mm during un-
treated IDDM (P < 0.05). In the treated IDDM group, GFRI100
g body weight did not increase during the time course of the
study (Fig. 5). Absolute GFR increased compared to the
pre-diabetic control measurements from 3.0 0.1 to 3.7 0.1
mllmin (P < 0.05) but this increase was consistent with growth
and significantly less than the increase observed in the un-
treated IDDM group (P < 0.05). There was no significant
change in GFRI100 g body weight in the time controls and only
modest increases in absolute GFR during the time course of the
study.
Renal plasma flow normalized to body weight demonstrated a
marked and consistent increase after streptozotocin induced
diabetes in the untreated IDDM group (Fig. 6). This increase in
RPF/100 g body weight did not occur with either the treated
IDDM group or the time controls (Fig. 6). In the untreated
IDDM group, absolute RPF during the overall period increased
from 11.8 0.3 in the pre-diabetic control measurements to
13.1 0.4 mI/mm (P < 0.05). In the treated IDDM group, RPF
* /
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Fig. 4. Alterations in sodium excretion rate during the first 15 days of
untreated (long dashed line) and insulin treated JDDM (short dashed
line). IDDM rats demonstrated a significant increase in UNaY in day 1
and remained elevated during the study period (P < 0.05). UNaV in TR
IDDM did not have the same magnitude of increase as in the IDDM rats
and at days 4 and 11 did not differ from time control values (solid line).
*D < 0.05 compared to respective day 0 measurements.
increased from 10.4 0.3 to 12.6 0.3 mL/min, but this
increment was consistent with growth during the study period.
The time controls demonstrated an initial RPF of 10.7 0.3
ml/min and did not significantly change during the remaining
period of the study (11.4 0.4 mllmin).
Effect of untreated and insulin treated diabetes on
extracellular fluid volume
Extracellular fluid volume (ECF, % of body wt) was not
significantly altered during the course of the study in the time
control group (indicated by the line in Fig. 7). However, after
streptozotocin induced diabetes in both the untreated and
treated groups, ECF decreased significantly after 24 hours and
remained at levels less than the pre-diabetic control measure-
ments during the entire 15 day course of the study (Fig. 7).
Overall, the decrease in ECF was greater in the untreated than
the treated diabetic group (P <0.05).
These data indicate that the early glomerular hyperfiltration
observed in untreated insulin-dependent diabetes is associated
with increases in renal plasma flow but cannot be correlated to
increased extracellular fluid volume.
Effect of untreated insulin dependent diabetes on plasma
volume
Plasma volume (PV) was 2.60 0.11% of body wt (11.6 0.8
ml) in the control rats, 2.53 0.14% of body wt (13.1 1.1 ml)
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Fig. 5. Changes in glomerular filtration rate (GFR) during the first 15
days of untreated (long dashed line) and insulin treated (short dashed
line) IDDM. IDDM rats exhibited an increased GFR after 24 hours and
continued to further increase during the 15 day study period. GFR in the
TR IDDM rats did not significantly change during the 15 day period and
were not different from the time controls (solid line) except at the day
15 time point. *p < 0.05 compared to respective day 0 measurements.
Fig. 7. Alterations in extracellular fluid volume (ECF) during the first
15 days of untreated (long dashed line) and insulin treated (short
dashed line) IDDM. ECF in IDDM rats significantly decreased in the
first 24 hours and remained at levels significantly less than control
measurements (P < 0.05) and was significantly less than the time
controls (excluding day 4). ECF in TR IDDM rats was also significantly
decreased compared to control (day 0) values (P < 0.05). The solid line
represents ECF in the time controls which did not change significantly
6 during the period of the study, *D < 0.05 compared to respective day 0
measurements.
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*,j.-/ insulin dependent diabetes. However, no plasma volume ex-pansion was observed to associate with the development of
glomerular hyperfiltration.
Discussion
.
E
.
Increases in glomerular filtration rate or hyperfiltration is a
common phenomena associated with insulin dependent diabe-
tes in both human and animal models [1—41. One school of
thought is that hyperfiltration in the clinical condition is asso-
ciated with eventual proteinuria and increasing glomerulopathy
leading to renal failure [5, 61. When blood glucose control is
0 I I
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Fig. 6. Changes in renal plasma flow (RPF) during the first 15 days of
untreated (long dashed line) and insulin treated (short dashed line)
IDDM. RPF in diabetic rats increased significantly after 24 hours
post-streptozotocin infusion and remained elevated for the duration of
the study (P < 0.05) as well as significantly differing from the time
control group. RPF in TR IDDM was not significantly changed from
control. The solid line represents the time controls and did not
significantly change during the time course of the study. *P < 0.05
compared to respective day 0 measurements.
after 24 hours of untreated streptozotocin-induced diabetes,
2.67 0.16% body wt (11.8 0.5 ml) after seven days, and 2.89
0.13% of body wt (12.1 0.8 ml) after 15 days. There were
no significant changes in PV either by absolute volume or by
percent of body wt at any time point during insulin dependent
diabetes compared to control values. py was maintained at
values not different from control values even though ECF
decreased significantly during the same time period in early
well maintained, hyperfiltration does not occur as observed in
the early stages of IDDM in the present study and in longer term
animal models of insulin dependent diabetes as well as in the
human [6]. Proper glycemic control has also been associated
with either a reduction or a prolongation of the onset of
proteinuria [25]. Several investigators have proposed that the
hyperfiltration in IDDM contributes, through glomerular capil-
lary hypertension, to the development of diabetic nephropathy
[5, 91. However, the mechanism(s) producing glomerular hyper-
filtration in IDDM is less well defined. A popular hypothesis is
that increased renal plasma flow resulting in glomerular hyper-
filtration is due to expansion of either plasma [3, 101 or
extracellular fluid volume [1, 101. There is some support for the
hypothesis that volume expansion provides the mechanism for
hyperfiltration. Hostetter, Troy and Brenner [3] found a 38%
increase in plasma volume after four to six weeks of poorly
controlled insulin-dependent diabetes in rats. Mogensen re-
ported increased ECF in humans with IDDM who also exhib-
ited increased GFR [1]. However, both clinical and animal
studies have been published demonstrating that plasma volume
and/or ECF was decreased in established insulin-dependent
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diabetes, in which hyperfiltration persisted [12, 131. The intent
of the present study was to determine if changes in ECF could
be related to changes in glomerular filtration rate from the onset
of streptozotocin induced diabetes in the rat. The awake animal
preparation was considered appropriate due to previous obser-
vations that anesthesia will cause a plasma volume/ECF shift
[26]. In addition, monitoring the pertinent values in an individ-
ual animal throughout the development of hyperfiltration pro-
vided a temporal criteria to link increased GFR to volume
expansion.
The findings of the present study indicate that ECF expansion
is not a requirement for increased glomerular filtration rate. In
fact, glomerular hyperfiltration developed under conditions of
volume depletion in the awake animal model of IDDM. These
data provide a strong argument for the dissociation of increased
GFR and ECF expansion. The increase in GFR was progressive
over time, whereas a reduction in ECF occurred within 24
hours of induction of diabetes and remained constant thereaf-
ter. Glomerular filtration increased rapidly in the untreated
IDDM group with significant increments achieved at 24 hours
after induction of insulin dependent diabetes. This elevation in
GFR was associated with increased plasma flow in the un-
treated IDDM group. Since the increase in GFR was almost
immediate, this change cannot be readily attributed to either
renal hypertrophy or morphologic alterations. Carney, Wong
and Dirks have also demonstrated early development of hyper-
filtration in the rat [271 but did not attribute the increase to any
specific mechanism. These data indicate that volume expansion
is an unlikely primary cause for the glomerular hyperfiltration
observed in early insulin dependent diabetes, although if
present, may further magnify the increases in GFR.
One potential cause for volume depletion in the untreated
IDDM group is the early observation of polyuria and increased
sodium excretion. Although fluid and electrolyte intake was not
monitored in this study, one can presume that at least sodium
balance was in deficit. The loss in fluid from the ECF is
approximately 34 ml after the first day based upon the untreated
rats' change in ECF (Figs. 1 and 7). However, body weight in
the untreated diabetic group only decreased by 8 2 g after 24
hours (Fig. 1). Therefore, extracorporeal losses cannot account
for the total decrease in ECF. The most likely reservoir for the
majority of fluid exiting the ECF is the intracellular space. In
the untreated IDDM group, if most of the shift of fluid was into
the intracellular space, this would be indicative of early intra-
cellular volume expansion with the intracellular space slowly
returning to original, prediabetic, volume status as the animal
lost weight during the time course of the study since ECF was
constant during the diabetic phase of this study (Fig. 7).
In the treated IDDM group, which were maintained with
relatively tight glycemic control, GFR and RPF normalized to
body weight remained constant. However, fractional ECF
decreased after 24 hours post-induction of streptozotocin and
remained at less than control values throughout the period of
the study, again, most likely a shift of fluid to intracellular
space. This decrease in ECF may have been maintained by
sodium losses due to increased sodium excretion that was not
compensated by increased intake, potentially due to episodic
hyperglycemia during periods when the renal function and ECF
measurements were not performed. It is evident in the present
study that insulin treatment did not ameliorate the decrease in
ECF, although GFR and RPF were normalized. In either case,
untreated or treated IDDM, if the volume status of the diabetic
rat is characterized by a decreased ECF, then dietary salt
restriction should have a considerable effect on GFR such that
even a small volume decrease in ECF of 5 to 10 ml could reduce
GFR. This was observed by Bank et a! [11] in hyperfiltering
diabetic rats in that GFR was normalized with decreased
sodium intake.
Plasma volume in the untreated diabetic rats did not increase
and cannot be a factor in the development of glomerular
hyperfiltration. Despite the significant decrease in ECF in
untreated diabetic rats, PV was maintained at values not
different from control. This shift in PV/ECF ratio may indicate
a change in the hydrostatic or oncotic forces at the peripheral
capillary beds modifying the intra- to extravascular fluid distri-
bution.
To summarize, the increase in glomerular filtration rate in
early streptozotocin induced diabetes is associated with an
increase in renal plasma flow, but there was no correlation of
GFR or RPF to changes in extracellular fluid or plasma volume.
The present study indicates that volume expansion need not be
a factor in the development of glomerular hyperfiltration ob-
served under the conditions of the present study. Factors other
than volume expansion should be considered as a mechanism
for the development of glomerular hyperfiltration in insulin
dependent diabetes. Both untreated and insulin treated IDDM
rats exhibited a decreased extracellular fluid volume compared
to control values, indicating that insulin treatment sufficient to
produce normoglycemia and maintain GFR and RPF at normal
values was unable to maintain a normal extracellular to intra-
cellular fluid balance.
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